Literature DB >> 18783831

Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines.

Q Michard1, G Jaouen, A Vessieres, B A Bernard.   

Abstract

Malignant melanoma is one of the most severe forms of skin cancer, and chemotherapeutic agents currently in use are poorly effective in curing the disease. Here we describe the properties of two organometallic ferrocenyl derivatives, ferrocifen (Fc-OH-Tam) and ferrociphenol (Fc-diOH) that show a specific antiproliferative effect on melanoma cells. After a short incubation period, Fc-OH-Tam is highly cytotoxic on melanoma cells but less toxic on melanocytes. Fc-diOH is slightly toxic at a high concentration but no discrepancy is observed between malignant and normal cells. After a long incubation time the latter is highly toxic for malignant cells but not for normal cells while the former was very highly toxic for primary malignant cells and significantly less toxic for normal cells. We also found that oxidative stress is not implicated in the mechanism of cytotoxicity, since both derivatives neither induce reactive oxygen species (ROS) level in melanocytes nor in melanoma cells. Finally, investigation on hair follicle growth revealed that the two organometallic derivatives induced an irreversible ejection of the hair shaft, thus predicting a potential hair loss side effect if used as a chemotherapeutic treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18783831     DOI: 10.1016/j.jinorgbio.2008.07.014

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  7 in total

1.  Some ferrocenyl chalcones as useful candidates for cancer treatment.

Authors:  Vašková Janka; Daniel Žatko; Vaško Ladislav; Perjési Pál; Poráčová Janka; Mojžišová Gabriela
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-28       Impact factor: 2.416

Review 2.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

3.  A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties.

Authors:  Yong Wang; Patrick M Dansette; Pascal Pigeon; Siden Top; Michael J McGlinchey; Daniel Mansuy; Gérard Jaouen
Journal:  Chem Sci       Date:  2017-11-16       Impact factor: 9.825

4.  In Vitro Anticancer Activity of Two Ferrocene-Containing Camphor Sulfonamides as Promising Agents against Lung Cancer Cells.

Authors:  Maria Schröder; Maria Petrova; Zlatina Vlahova; Georgi M Dobrikov; Ivaylo Slavchev; Evdokia Pasheva; Iva Ugrinova
Journal:  Biomedicines       Date:  2022-06-08

Review 5.  Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.

Authors:  Pierre Idlas; Elise Lepeltier; Gérard Jaouen; Catherine Passirani
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

6.  2,2'-Bipyridine-Modified Tamoxifen: A Versatile Vector for Molybdacarboranes.

Authors:  Benedikt Schwarze; Sanja Jelača; Linda Welcke; Danijela Maksimović-Ivanić; Sanja Mijatović; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2019-11-18       Impact factor: 3.466

7.  Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines.

Authors:  Márton Kalabay; Zsófia Szász; Orsolya Láng; Eszter Lajkó; Éva Pállinger; Cintia Duró; Tamás Jernei; Antal Csámpai; Angéla Takács; László Kőhidai
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.